Literature DB >> 1854979

Randomized study of mammography screening--preliminary report on mortality in the Stockholm trial.

J Frisell1, G Eklund, L Hellström, E Lidbrink, L E Rutqvist, A Somell.   

Abstract

In March 1981, 40,318 women in Stockholm, aged 40-64, entered a randomized trial of breast cancer screening by single-view mammography alone versus no intervention in a control group of 20,000 women. The attendance rate during the first screening round was 81 per cent and the cancer detection rate was 4.0 per 1000 women. The detection the rate fell to 3.1 per 1000 in the second round, which was completed in October 1985. During 1986 the controlled design of the study was broken and the control women were invited once to screening which was completed the same year. A total of 428 cases of breast cancer were thus diagnosed in the study group and 439 in the adjusted control group. After a mean follow-up of 7.4 years the number of breast cancer deaths in the study and control groups was 39 and 30 respectively. The relative risk of breast cancer death (screening versus control) was 0.71 (95 per cent confidence interval: 0.4-1.2). Among women older than 50 years at entry the relative risk was 0.57 (95 percent confidence interval: 0.3-1.1). Cancer deaths among women under 50 were few and perhaps because of this no mortality reduction was seen in this age group. The estimate of mortality reduction lies between the results from two earlier Swedish randomized controlled trials.

Entities:  

Mesh:

Year:  1991        PMID: 1854979     DOI: 10.1007/bf01975443

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  21 in total

1.  Edinburgh trial of screening for breast cancer: mortality at seven years.

Authors:  M M Roberts; F E Alexander; T J Anderson; U Chetty; P T Donnan; P Forrest; W Hepburn; A Huggins; A E Kirkpatrick; J Lamb
Journal:  Lancet       Date:  1990-02-03       Impact factor: 79.321

2.  First results on mortality reduction in the UK Trial of Early Detection of Breast Cancer. UK Trial of Early Detection of Breast Cancer Group.

Authors: 
Journal:  Lancet       Date:  1988-08-20       Impact factor: 79.321

3.  A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma.

Authors:  P R Rosen; S Groshen; P E Saigo; D W Kinne; S Hellman
Journal:  J Clin Oncol       Date:  1989-03       Impact factor: 44.544

4.  Reduction of breast cancer mortality through mass screening with modern mammography. First results of the Nijmegen project, 1975-1981.

Authors:  A L Verbeek; J H Hendriks; R Holland; M Mravunac; F Sturmans; N E Day
Journal:  Lancet       Date:  1984-06-02       Impact factor: 79.321

5.  Radiographic screening for breast carcinoma. I. Program and primary findings in 45--69 year old women.

Authors:  I Andersson
Journal:  Acta Radiol Diagn (Stockh)       Date:  1981

6.  Effects of repeated mammographic screening on breast cancer stage distribution. Results from a randomised study of 92 934 women in a Swedish county.

Authors:  G Fagerberg; L Baldetorp; O Gröntoft; B Lundström; J C Månson; B Nordenskjöld
Journal:  Acta Radiol Oncol       Date:  1985 Nov-Dec

7.  Is breast cancer a curable disease? A study of 14,731 women with breast cancer from the Cancer Registry of Norway.

Authors:  L E Rutqvist; A Wallgren; B Nilsson
Journal:  Cancer       Date:  1984-04-15       Impact factor: 6.860

8.  Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial.

Authors:  I Andersson; K Aspegren; L Janzon; T Landberg; K Lindholm; F Linell; O Ljungberg; J Ranstam; B Sigfússon
Journal:  BMJ       Date:  1988-10-15

9.  Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare.

Authors:  L Tabár; C J Fagerberg; A Gad; L Baldetorp; L H Holmberg; O Gröntoft; U Ljungquist; B Lundström; J C Månson; G Eklund
Journal:  Lancet       Date:  1985-04-13       Impact factor: 79.321

10.  What is the optimum interval between mammographic screening examinations? An analysis based on the latest results of the Swedish two-county breast cancer screening trial.

Authors:  L Tabár; G Faberberg; N E Day; L Holmberg
Journal:  Br J Cancer       Date:  1987-05       Impact factor: 7.640

View more
  34 in total

1.  Aggressiveness of breast cancers detected by screening.

Authors:  S W Duffy
Journal:  BMJ       Date:  1992-05-23

Review 2.  Statistical analyses in Swedish randomised trials on mammography screening and in other randomised trials on cancer screening: a systematic review.

Authors:  Philippe Autier; Mathieu Boniol; Michel Smans; Richard Sullivan; Peter Boyle
Journal:  J R Soc Med       Date:  2015-07-07       Impact factor: 5.344

3.  Mammography and the politics of randomised controlled trials.

Authors:  J Wells
Journal:  BMJ       Date:  1998-10-31

4.  Effect of VIA screening by primary health workers: randomized controlled study in Mumbai, India.

Authors:  Surendra S Shastri; Indraneel Mittra; Gauravi A Mishra; Subhadra Gupta; Rajesh Dikshit; Shalini Singh; Rajendra A Badwe
Journal:  J Natl Cancer Inst       Date:  2014-02-22       Impact factor: 13.506

5.  Factors associated with women's adherence to mammography screening guidelines.

Authors:  K A Phillips; K Kerlikowske; L C Baker; S W Chang; M L Brown
Journal:  Health Serv Res       Date:  1998-04       Impact factor: 3.402

6.  Were our estimates of overdiagnosis with mammography screening in the United States "based on faulty science"?

Authors:  Archie Bleyer
Journal:  Oncologist       Date:  2014-02

7.  Standardized uptake values of normal breast tissue with 2-deoxy-2-[F-18]fluoro-D: -glucose positron emission tomography: variations with age, breast density, and menopausal status.

Authors:  Rakesh Kumar; Anil Chauhan; Hongming Zhuang; Prem Chandra; Mitchell Schnall; Abass Alavi
Journal:  Mol Imaging Biol       Date:  2006 Nov-Dec       Impact factor: 3.488

8.  Mortality from breast cancer in Ireland prior to the introduction of population-based mammographic screening.

Authors:  M B Codd; J Buttimer; H Comber; J Stack; T F Gorey
Journal:  Ir J Med Sci       Date:  1999 Apr-Jun       Impact factor: 1.568

9.  Screening mammography intervals among postmenopausal hormone therapy users and nonusers.

Authors:  Tracy Onega; Todd MacKenzie; Julia Weiss; Martha Goodrich; Linda Titus-Ernstoff
Journal:  Cancer Causes Control       Date:  2009-10-21       Impact factor: 2.506

10.  Effect of mammographic breast density on breast cancer screening performance: a study in Nijmegen, The Netherlands.

Authors:  C H van Gils; J D Otten; A L Verbeek; J H Hendriks; R Holland
Journal:  J Epidemiol Community Health       Date:  1998-04       Impact factor: 3.710

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.